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Plexiform neuroﬁbromas occur in about 60% of neuroﬁbromatosis type 1(NF-1) patients and can lead to severe morbidity by
disﬁgurement or compression of vital structures. Moreover, these tumors can undergo malignant transformation. Both focal and
localized bone abnormalities are part of the phenotypic expression of NF-1. We report a rare case of severe cranioorbital plexiform
neuroﬁbromatosisinayoungmaleanddiscusstheclassiﬁcation,clinical features,andvarioustreatmentoptionsoforbit-temporal
neuroﬁbromatosis type 1.
1.Introduction
Neuroﬁbromatosis type 1 or von Recklinghausen disease is
an autosomal dominant genetic disorder, aﬀecting approxi-
mately 1 in 3000 individuals [1]. Patients present with cu-
taneous plexiform neuroﬁbromas which can undergo trans-
formation to malignant peripheral nerve sheath tumors and
rarely orbital abnormality.
2. Case Presentation
A 19-years-old Asian-Indian male presented in our oculo-
plasty department with complaints of painless progressive
swelling around the right eye and right half of the face with
protrusion of right eye since childhood. He gave history
of surgical removal of the swelling elsewhere 10 years back
followed by recurrence. External examination revealed severe
ptosis in the right eye occluding visual axis and eccentric
proptosis with the globe displaced inwards and medially. The
lateral orbital rim was deformed with lower lid mechanical
ectropion due to a soft tissue mass which had a “bag of
worms” consistency on palpation (Figure 1). His vision was
1/60; N36 in the right and 6/6; N6 in the left eye. Right
eye showed relative aﬀerent pupillary defect and limited
abduction. Slit lamp examination of the right eye showed
temporal scleral thinning, clear cornea, and quiet anterior
chamber with normal depth, partial posterior embryotoxon
and clear lens. Lisch nodules were seen in both the eyes.
Intraocular pressure with applanation tonometer was 18 and
12mm of Hg in the right and left eyes, respectively.
Fundus examination of right eye showed attached retina
andnormalmaculawithatiltedopticdiscwithcupdiscratio
of 0.5:1 in both eyes. Left eye fundus was within normal
limits. No other stigmata of neuroﬁbromatosis were noted
in the patient. MRI of the brain and orbits showed complete
absence of the right greater wing, lesser wing, and half of the
body of the sphenoid with herniation of the temporal lobe in
the orbit (Figure 2). Multiple lobulated ill-deﬁned soft tissue
lesions were seen in the right forehead, temporal fossa, right
preseptal soft tissue, cheek, infratemporal fossa, pterygopala-
tine fossa, and masticator space. The lesions were isointense
in T1-weighted images and heterogeneously hyperintense
signal in T2-weighted images. The clinical examination and
imaging were diagnostic of plexiform neuroﬁbromatosis.
3. Discussion
Neuroﬁbromatosis type I is one of the common single-gene
disorders involving approximately 1:3000 individuals. The
diagnosis of NF-I should meet at least two of the following2 Case Reports in Ophthalmological Medicine
Figure 1: Clinical picture of the patient showing plexiform neuroﬁbromatosis.
Figure 2:MRIofthebrainaxial,coronal,andsagittalviewsshowingtheabsenceofrightsphenoidwingwithherniationofthetemporallobe.
criteria: (1) six or more caf´ e-au-lait spots (15mm or larger
after puberty and 5mm or more in prepubertal individuals);
(2) two or more neuroﬁbromas of any type or one or more
plexiform neuroﬁbroma; (3) freckling in the axilla or groin;
(4) optic glioma (tumor of optic pathway); (5) two or more
Lisch nodules (benign iris hamartomas); (6) a distinctive
bony lesion such as sphenoid wing dysplasia or thinning of
the cortex of the bones; (7) a ﬁrst-degree relative with NF-I
[1].
Plexiform neuroﬁbroma of the eyelid predominantly in-
volves the upper lid which manifests as an S-shaped mechan-
ical ptosis. Prominent corneal nerves are seen occasionally.
Lisch nodules arise in the ﬁrst decade and virtually all pa-
tients with NF-1 have them by 20 years. These nodules are
melanocytic hamartomas, clear yellow to brown in color that
appear as well deﬁned, and smooth dome-shaped elevations
projecting from the surface of the iris and often bilateral [2].
Less than 1% of patients suﬀering from NF-1 are report-
ed to have abnormalities of the orbit [3]. Jackson et al. clas-
siﬁed orbitotemporal neuroﬁbromatosis into three groups
[4]. First group had orbital soft-tissue involvement with a
seeing eye. Krohel et al. advocated intact removal of a well-
circumscribed lesion through an anterolateral orbitotomy
[5]. Plexiform neuroﬁbromas with diﬀuse soft tissue inﬁl-
tration make complete resection diﬃcult. Recurrent growth
may lead to repeated surgeries and cosmetic deformity [6].
Surgical debulking can be done via an anterior, lateral, or
anterolateral orbitotomy. Conservative blepharoptosis repair
in patients with amblyopia may be suﬃcient. Second
group had orbital soft-tissue and signiﬁcant bony involve-
ment with a seeing eye. In such patients an intracranial
approach provides superior exposure and visualization for
tumourdebulkingandposterolateralorbitalwallreconstruc-
tion. This approach was ﬁrst described by Marchac where
a bilateral frontal bone ﬂap is raised and the herniated
temporal lobe is reduced into the middle-cranial fossa [7].
The lesion in the orbit is debulked. Opposite side frontal
bone ﬂap is split and the inner table is contoured to ﬁll the
defect of the roof and posterior wall of the orbit. Lateral
orbital wall and ﬂoor are reconstructed. Surgical correction
through an intracranial approach is associated with a higher
complicationrate.Friedrichetal.suggestedthelateralorbital
approach as an alternative technique, using intraoperative
navigation system [8]. The use of computer-assisted simu-
lation and navigation systems for the exploration of complex
anatomic areas like the orbit has been reported to shorten
overall operation time and to increase the safety of surgical
maneuvers near delicate structures [9]. Third group had
orbital soft-tissue and bony involvement with a blind, mal-
positioned eye. Treatment of such patients is limited to
aesthetic procedures. Orbital exenteration is a viable option
and often produces the best cosmetic results which may
relieve the patient from major psychosocial distress due to
facial disﬁgurement [3]. During surgery, the greater wing of
sphenoid is reconstructed with split rib grafts. The superior
and inferior orbital rims along with orbital ﬂoor are
reconstructed and orbital prosthesis is placed at a later date.
If the tumor is large and stable without progression, then
observation may be a prudent option [8]. Our patient be-
longed to the third group who had orbital plexiform neu-
roﬁbroma with sphenoid wing aplasia and a densely ambly-
opic eye. He was explained about the surgical options andCase Reports in Ophthalmological Medicine 3
the possible complications. He was not willing for any sur-
gical intervention and hence was advised to follow up at
regular intervals. Orbitotemporal neuroﬁbromatosis being
a rare entity with limited literature, management has been a
challenging task for ophthalmologists, plastic surgeons, and
neurosurgeons. With the advancement in technology, the
management should depend on the clinical features, the ex-
tent of involvement, and the patient’s expectations.
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